Targeting Mechanisms for Natural Killer Cell Dysfunction in Patients with Multiple Myeloma

被引：0
|
作者：
Jenkins, Misty [1 ]
Canfield, Rachael [1 ]
Robbins, Michael [2 ]
Ritchie, David S. [3 ]
Trapani, Joe [1 ]
Neeson, Paul [4 ]
机构：
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
[2] Bristol Myers Squibb, Princeton, NJ USA
[3] Royal Melbourne Hosp, Parkville, Vic 3050, Australia
[4] Peter MacCallum Canc Ctr, Canc Immunol Res, Melbourne, Vic, Australia
来源：
BLOOD | 2015年 / 126卷 / 23期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Harnessing natural killer cells for the treatment of multiple myeloma
    Clara, Joseph A.
    Childs, Richard W.
    SEMINARS IN ONCOLOGY, 2022, 49 (01) : 69 - 85
  • [22] The Potential for Cancer Immunotherapy in Targeting Surgery-Induced Natural Killer Cell Dysfunction
    Market, Marisa
    Baxter, Katherine E.
    Angka, Leonard
    Kennedy, Michael A.
    Auer, Rebecca C.
    CANCERS, 2019, 11 (01):
  • [23] The effect of elotuzumab on natural killer (NK) cell function against multiple myeloma (MM).
    Collins, S. M.
    Bakan, C. E.
    Alghothani, Y.
    Kwon, H.
    Balasa, B.
    Starling, G.
    Rice, A.
    Benson, D. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [24] Restoring Natural Killer Cell immunity against Multiple Myeloma in the era of New Drugs
    Pittari, Gianfranco
    Vago, Luca
    Festuccia, Moreno
    Bonini, Chiara
    Mudawi, Deena
    Giaccone, Luisa
    Bruno, Benedetto
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [25] FRIEND OR FOE: NATURAL KILLER CELL AND MACROPHAGE BIDIRECTIONAL CROSS TALK IN MULTIPLE MYELOMA
    Ehlers, Femke A. I.
    Mahaweni, Niken
    Waterweg-Berends, Annet
    Bos, Gerard
    Wieten, Lotte
    HLA, 2020, 95 (04) : 355 - 355
  • [26] Tuning Natural Killer Cell Anti-multiple Myeloma Reactivity by Targeting Inhibitory Signaling via KIR and NKG2A
    Mahaweni, Niken M.
    Ehlers, Femke A. I.
    Bos, Gerard M. J.
    Wieten, Lotte
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [27] Targeting myeloma cell growth factors in multiple myeloma
    Klein, B.
    Hose, D.
    Moreaux, J.
    De Vos, J.
    Jourdan, M.
    Sprinsky, A. C.
    Jourdan, E.
    Reme, T.
    Mahtouk, K.
    Goldschmidt, H.
    Rossi, J. F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 43 - 44
  • [28] CIRCULATING MICROVESCULARS OF PATIENTS WITH MULTIPLE MYELOMA INHIBIT THE CITOTOXIC FUNCTION OF NATURAL KILLER CELLS
    Algarin, E. M.
    Paino, T.
    Anton, P.
    Diaz Tejedor, A.
    Corchete, L.
    Martin Sanchez, M.
    San Segundo, L.
    Gonzalez Mendez, L.
    Hernandez Garcia, S.
    Lopez Iglesias, A. A.
    Mogollon, P.
    Muntion, S.
    Sanchez Guijo, F.
    Mateos, M. V.
    Gutierrez, N. C.
    Ocio, E.
    Garayoa, M.
    HAEMATOLOGICA, 2017, 102 : 9 - 10
  • [29] Factors Affecting Natural Killer Cell Recovery after Autologous Stem Cell Transplantation in Multiple Myeloma
    Keruakous, Amany R.
    Aljumaily, Raid
    Zhao, Daniel
    Asch, Adam S.
    Yuen, Carrie
    BLOOD, 2021, 138
  • [30] INDIVIDUALIZED GENETIC MAKEUP THAT CONTROLS NATURAL KILLER CELL FUNCTION INFLUENCES THE EFFICACY OF ISATUXIMAB IMMUNOTHERAPY IN PATIENTS WITH MULTIPLE MYELOMA
    Rajalingam, R.
    Sun, H.
    Kong, D.
    Mace, S.
    Chiron, M.
    HUMAN IMMUNOLOGY, 2021, 82 : 103 - 104
12345